Therapeutic Plasma Exchange Market 2027 by Type, Application | The Insight Partners

Therapeutic Plasma Exchange Market Forecast to 2027 - Covid-19 Impact and Global Analysis - by Type (Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders, Others); Application (Hospitals, Specialty Clinics, Ambulatory Surgical Centers)

Report Code: TIPRE00008480 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
Covid
MARKET INTRODUCTION

Therapeutic Plasma Exchange (TPE) is a procedure in which the patient's blood is passed through an apheresis machine, where the filtered plasma is removed and discarded with reinfusion of red blood cells along with replacement fluid such as plasma. Plasma exchange, also known as plasmapheresis, is a way to "clean" your blood. It works sort of like kidney dialysis. During the treatment, plasma the liquid part of blood gets replaced with plasma from a donor or with a plasma substitute.

MARKET DYNAMICS

The therapeutic plasma exchange market is anticipated to increase in investments by leading market players. Moreover, rapid expansion and an increase in a number of research and academic institutes in these regions are expected to drive the demand for therapeutic plasma exchange procedures during the forecast period.

MARKET SCOPE

The "Therapeutic Plasma Exchange Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of in therapeutic plasma exchange market with detailed market segmentation by type, application and geography. The therapeutic plasma exchange market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in therapeutic plasma exchange market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The therapeutic plasma exchange market is segmented on the basis of type and application. Based on type the market is segmented as neurological disorders, renal disorders, hematology disorders, metabolic disorders and others. On the basis of application the market is categorized as hospitals, specialty clinics and ambulatory surgical centers.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in therapeutic plasma exchange market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The therapeutic plasma exchange market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting therapeutic plasma exchange market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the therapeutic plasma exchange market in these regions.




Get more information on this report :

MARKET PLAYERS


The report covers key developments in the in therapeutic plasma exchange market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in therapeutic plasma exchange market are anticipated to have lucrative growth opportunities in the future with the rising demand for in therapeutic plasma exchange market in the global market. Below mentioned is the list of few companies engaged in the therapeutic plasma exchange market.

The report also includes the profiles of key in therapeutic plasma exchange market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Asahi Kasei Corporation
- B. Braun Melsungen AG
- Baxter International, Inc.
- Cerus Corporation
- Fresenius Kabi AG
- Haemonetics Corporation
- Hemacare Corporation
- Kawasumi Laboratories, Inc.
- Medica S.p.A
- Terumo Corporation

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Therapeutic Plasma Exchange Market - By Type
1.3.2 Therapeutic Plasma Exchange Market - By Application
1.3.3 Therapeutic Plasma Exchange Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. THERAPEUTIC PLASMA EXCHANGE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. THERAPEUTIC PLASMA EXCHANGE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. THERAPEUTIC PLASMA EXCHANGE MARKET - GLOBAL MARKET ANALYSIS
6.1. THERAPEUTIC PLASMA EXCHANGE - GLOBAL MARKET OVERVIEW
6.2. THERAPEUTIC PLASMA EXCHANGE - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. THERAPEUTIC PLASMA EXCHANGE MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. NEUROLOGICAL DISORDERS
7.3.1. Overview
7.3.2. Neurological Disorders Market Forecast and Analysis
7.4. RENAL DISORDERS
7.4.1. Overview
7.4.2. Renal Disorders Market Forecast and Analysis
7.5. HEMATOLOGY DISORDERS
7.5.1. Overview
7.5.2. Hematology Disorders Market Forecast and Analysis
7.6. METABOLIC DISORDERS
7.6.1. Overview
7.6.2. Metabolic Disorders Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. THERAPEUTIC PLASMA EXCHANGE MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. SPECIALTY CLINICS
8.4.1. Overview
8.4.2. Specialty Clinics Market Forecast and Analysis
8.5. AMBULATORY SURGICAL CENTERS
8.5.1. Overview
8.5.2. Ambulatory Surgical Centers Market Forecast and Analysis
9. THERAPEUTIC PLASMA EXCHANGE MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Therapeutic Plasma Exchange Market Overview
9.1.2 North America Therapeutic Plasma Exchange Market Forecasts and Analysis
9.1.3 North America Therapeutic Plasma Exchange Market Forecasts and Analysis - By Type
9.1.4 North America Therapeutic Plasma Exchange Market Forecasts and Analysis - By Application
9.1.5 North America Therapeutic Plasma Exchange Market Forecasts and Analysis - By Countries
9.1.5.1 United States Therapeutic Plasma Exchange Market
9.1.5.1.1 United States Therapeutic Plasma Exchange Market by Type
9.1.5.1.2 United States Therapeutic Plasma Exchange Market by Application
9.1.5.2 Canada Therapeutic Plasma Exchange Market
9.1.5.2.1 Canada Therapeutic Plasma Exchange Market by Type
9.1.5.2.2 Canada Therapeutic Plasma Exchange Market by Application
9.1.5.3 Mexico Therapeutic Plasma Exchange Market
9.1.5.3.1 Mexico Therapeutic Plasma Exchange Market by Type
9.1.5.3.2 Mexico Therapeutic Plasma Exchange Market by Application
9.2. EUROPE
9.2.1 Europe Therapeutic Plasma Exchange Market Overview
9.2.2 Europe Therapeutic Plasma Exchange Market Forecasts and Analysis
9.2.3 Europe Therapeutic Plasma Exchange Market Forecasts and Analysis - By Type
9.2.4 Europe Therapeutic Plasma Exchange Market Forecasts and Analysis - By Application
9.2.5 Europe Therapeutic Plasma Exchange Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Therapeutic Plasma Exchange Market
9.2.5.1.1 Germany Therapeutic Plasma Exchange Market by Type
9.2.5.1.2 Germany Therapeutic Plasma Exchange Market by Application
9.2.5.2 France Therapeutic Plasma Exchange Market
9.2.5.2.1 France Therapeutic Plasma Exchange Market by Type
9.2.5.2.2 France Therapeutic Plasma Exchange Market by Application
9.2.5.3 Italy Therapeutic Plasma Exchange Market
9.2.5.3.1 Italy Therapeutic Plasma Exchange Market by Type
9.2.5.3.2 Italy Therapeutic Plasma Exchange Market by Application
9.2.5.4 Spain Therapeutic Plasma Exchange Market
9.2.5.4.1 Spain Therapeutic Plasma Exchange Market by Type
9.2.5.4.2 Spain Therapeutic Plasma Exchange Market by Application
9.2.5.5 United Kingdom Therapeutic Plasma Exchange Market
9.2.5.5.1 United Kingdom Therapeutic Plasma Exchange Market by Type
9.2.5.5.2 United Kingdom Therapeutic Plasma Exchange Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Therapeutic Plasma Exchange Market Overview
9.3.2 Asia-Pacific Therapeutic Plasma Exchange Market Forecasts and Analysis
9.3.3 Asia-Pacific Therapeutic Plasma Exchange Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Therapeutic Plasma Exchange Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Therapeutic Plasma Exchange Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Therapeutic Plasma Exchange Market
9.3.5.1.1 Australia Therapeutic Plasma Exchange Market by Type
9.3.5.1.2 Australia Therapeutic Plasma Exchange Market by Application
9.3.5.2 China Therapeutic Plasma Exchange Market
9.3.5.2.1 China Therapeutic Plasma Exchange Market by Type
9.3.5.2.2 China Therapeutic Plasma Exchange Market by Application
9.3.5.3 India Therapeutic Plasma Exchange Market
9.3.5.3.1 India Therapeutic Plasma Exchange Market by Type
9.3.5.3.2 India Therapeutic Plasma Exchange Market by Application
9.3.5.4 Japan Therapeutic Plasma Exchange Market
9.3.5.4.1 Japan Therapeutic Plasma Exchange Market by Type
9.3.5.4.2 Japan Therapeutic Plasma Exchange Market by Application
9.3.5.5 South Korea Therapeutic Plasma Exchange Market
9.3.5.5.1 South Korea Therapeutic Plasma Exchange Market by Type
9.3.5.5.2 South Korea Therapeutic Plasma Exchange Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Therapeutic Plasma Exchange Market Overview
9.4.2 Middle East and Africa Therapeutic Plasma Exchange Market Forecasts and Analysis
9.4.3 Middle East and Africa Therapeutic Plasma Exchange Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Therapeutic Plasma Exchange Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Therapeutic Plasma Exchange Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Therapeutic Plasma Exchange Market
9.4.5.1.1 South Africa Therapeutic Plasma Exchange Market by Type
9.4.5.1.2 South Africa Therapeutic Plasma Exchange Market by Application
9.4.5.2 Saudi Arabia Therapeutic Plasma Exchange Market
9.4.5.2.1 Saudi Arabia Therapeutic Plasma Exchange Market by Type
9.4.5.2.2 Saudi Arabia Therapeutic Plasma Exchange Market by Application
9.4.5.3 U.A.E Therapeutic Plasma Exchange Market
9.4.5.3.1 U.A.E Therapeutic Plasma Exchange Market by Type
9.4.5.3.2 U.A.E Therapeutic Plasma Exchange Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Therapeutic Plasma Exchange Market Overview
9.5.2 South and Central America Therapeutic Plasma Exchange Market Forecasts and Analysis
9.5.3 South and Central America Therapeutic Plasma Exchange Market Forecasts and Analysis - By Type
9.5.4 South and Central America Therapeutic Plasma Exchange Market Forecasts and Analysis - By Application
9.5.5 South and Central America Therapeutic Plasma Exchange Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Therapeutic Plasma Exchange Market
9.5.5.1.1 Brazil Therapeutic Plasma Exchange Market by Type
9.5.5.1.2 Brazil Therapeutic Plasma Exchange Market by Application
9.5.5.2 Argentina Therapeutic Plasma Exchange Market
9.5.5.2.1 Argentina Therapeutic Plasma Exchange Market by Type
9.5.5.2.2 Argentina Therapeutic Plasma Exchange Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. THERAPEUTIC PLASMA EXCHANGE MARKET, KEY COMPANY PROFILES
11.1. ASAHI KASEI CORPORATION
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. B. BRAUN MELSUNGEN AG
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. BAXTER INTERNATIONAL, INC.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. CERUS CORPORATION
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. FRESENIUS KABI AG
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. HAEMONETICS CORPORATION
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. HEMACARE CORPORATION
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. KAWASUMI LABORATORIES, INC.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. MEDICA S.P.A
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. TERUMO CORPORATION
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Asahi Kasei Corporation
2. B. Braun Melsungen AG
3. Baxter International, Inc.
4. Cerus Corporation
5. Fresenius Kabi AG
6. Haemonetics Corporation
7. Hemacare Corporation
8. Kawasumi Laboratories, Inc.
9. Medica S.p.A
10. Terumo Corporation
TIPRE00008480
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking